Envista (NYSE:NVST) Given New $21.00 Price Target at Wells Fargo & Company

Envista (NYSE:NVST) had its price target boosted by Wells Fargo & Company from $20.00 to $21.00 in a research report report published on Thursday,Benzinga reports. They currently have an equal weight rating on the stock.

A number of other brokerages also recently commented on NVST. Needham & Company LLC reissued a “hold” rating on shares of Envista in a research report on Thursday. Morgan Stanley upped their price target on Envista from $19.00 to $20.00 and gave the company an “equal weight” rating in a report on Thursday. Piper Sandler upped their price target on Envista from $17.00 to $18.00 and gave the company a “neutral” rating in a report on Monday. Jefferies Financial Group upped their price target on Envista from $20.00 to $22.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. Finally, Stifel Nicolaus upped their price target on Envista from $18.00 to $21.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Two analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $20.21.

Envista Stock Up 5.8 %

Shares of Envista stock opened at $21.76 on Thursday. Envista has a one year low of $15.15 and a one year high of $24.79. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.08 and a quick ratio of 1.77. The business has a 50-day simple moving average of $19.97 and a 200-day simple moving average of $19.10.

Envista (NYSE:NVST) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $0.24 EPS for the quarter, topping analysts’ consensus estimates of $0.23 by $0.01. Envista had a positive return on equity of 3.76% and a negative net margin of 53.42%. On average, sell-side analysts forecast that Envista will post 0.72 earnings per share for the current year.

Institutional Investors Weigh In On Envista

Several large investors have recently modified their holdings of NVST. Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of Envista during the third quarter worth approximately $31,000. GAMMA Investing LLC raised its stake in shares of Envista by 69.8% during the third quarter. GAMMA Investing LLC now owns 1,766 shares of the company’s stock worth $35,000 after purchasing an additional 726 shares during the last quarter. Huntington National Bank raised its stake in shares of Envista by 97.8% during the third quarter. Huntington National Bank now owns 1,919 shares of the company’s stock worth $38,000 after purchasing an additional 949 shares during the last quarter. Venturi Wealth Management LLC raised its position in Envista by 528.4% in the fourth quarter. Venturi Wealth Management LLC now owns 1,948 shares of the company’s stock worth $38,000 after acquiring an additional 1,638 shares in the last quarter. Finally, Blue Trust Inc. raised its position in Envista by 69.7% in the third quarter. Blue Trust Inc. now owns 1,957 shares of the company’s stock worth $39,000 after acquiring an additional 804 shares in the last quarter.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.